The study highlights the prognostic and therapeutic role of SNHG16 in lung cancer and advocates the targeting of SNHG16/ALDH2 axis as potential and novel anticancer strategy against the devastating malignancy of human lung cancer. The gene discussed is ALDH2; the disease is lung carcinoma.